After the introduction of corticosteroids, mortality rapidly dropped to less than 10%, and is currently reported to be less than 2% to 3%. Because most children ...

23 окт. 2024 г. · In general, children with JDM are able to lead normal lives with full recovery, compared with adults. Delayed or inadequate treatment with ... Practice Essentials · Background · Etiology

Severe weakness when moving, swallowing or breathing. Death. Before treatment was available, about 1 in 3 children would die from juvenile dermatomyositis. Now ...

1 янв. 2022 г. · Prognosis. Before the introduction of corticosteroid treatment, prognosis in JDM is very poor, with one third of the patients recovering without ...

The course of JDM is highly variable: 30-50% patients go into remission within 2 to 3 years, whilst others have a cyclic course marked by relapse or an ...

Conclusions. The prognosis of JDM and the related childhood IIM has improved dramatically in recent years. Despite this, these conditions remain serious and ...

With adequate treatment some children lead normal lives with full recovery. However, a significant proportion have a prolonged course with residual muscle ...

Many children will recover from JDM without any lasting problems. Some children may have trouble moving because of shortening of the joints (contractures). Some ...

There is no cure for juvenile dermatomyositis. However, with a team approach to treatment, remission of the disease is usually achieved. Treatment typically ...